medondo holding AG, together with its subsidiaries, provides software solutions in Germany. The company offers Online Diary, an online appointment calendar; digital anamnesis & clarification, which records patient's relevant health information before the appointment; practice marketing & visibility that publishes regular specialist articles in practice blog, as well as publish specialist articles on channels for an online presence; Form Designer that create customized forms; and Patient Portal, which make documents and forms available digitally and enable patients to make appointments and follow-up appointments. It also provides self-check-in; digital patient file, which provides information about patients; practice TV & patient management that integrates the patient call function directly into the practice TV; co-treatment portal, which shares findings, X-ray images or treatment reports; and digital documents & signature that provides patients with important documents digitally via the patient portal or by e-mail and have documents signed electronically. In addition, the company offers digital invoices; follow-up appointment management & appointment reminders; digital medical history & explanation; digital patient record; digital factoring; quality management & documentation; and appointment quotas & controlling software. Further, it provides product-related services, such as training, consulting, maintenance, and support services. The company was founded in 2003 and is based in Munich, Germany.
Research context
amalphi ag appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Technology
- Industry
- Information Technology Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
amalphi ag is currently in a long term uptrend where the price is trading 8.5% above its 200 day moving average.
From a valuation standpoint, the stock is 85.4% cheaper than other stocks from the Technology sector with a price to sales ratio of 2.0.
Based on the above factors, amalphi ag gets an overall score of 2/5.